United Health Products Receives Notice of Allowance for Patent Application for HemoStyp™ Gauze Product - Anticipates First ...
September 16 2013 - 8:34AM
Business Wire
United Health Products, Inc. (OTCQB: UEEC) announced that it has
received formal notification of allowance of its patent application
from the U.S. Patent Office for its hemostatic gauze product,
HemoStyp™, and that the patent will issue shortly. The Company is
also pursuing additional applications and filings for its HemoStyp
product line.
HemoStyp is an all-natural product comprised of regenerated
oxidized cellulose gauze which is specifically formulated to aid in
the process of hemostasis (clotting) when positioned on a cut or
wound. Unlike the other products in the wound care market, HemoStyp
contains no potentially harmful chemicals or animal byproducts and
is hypoallergenic. Once it has completed its task, it is easily
removed by dissolving it in water or saline solution. This method
of removal neither disturbs the clotted surface nor encourages
re-bleeding.
Dr. Phillip Forman, CEO of United Health Products, stated that,
"Now that the Company has obtained full patent rights for HemoStyp,
we look forward to entering the next phase of sales and marketing
with our patented product."
The Company expects its first orders from the dental and medical
markets as it is now pursuing multiple markets for HemoStyp
including the medical, sports, dental, military, and veterinary
sectors, each of which represents a multimillion dollar market.
About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures, and
markets a patented hemostatic gauze, for the healthcare and wound
care sectors. The product, HemoStyp™, is derived from regenerated
oxidized cellulose, which is all natural, and designed to absorb
exudate/drainage from superficial wounds and helps control
bleeding. UEEC is focused on identifying new markets and
applications for its product as well as ramping up sales in its
current markets. For more on United Health Products, Inc. visit:
www.unitedhealthproductsinc.com.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release may contain forward-looking
information within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including statements that include the words
"believes," "expects," "anticipates" or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the Company to differ materially
from those expressed or implied by such forward-looking
statements.
Company Contact:United Health Products, Inc.Dr. Philip
Forman, CEO646-808-3104orIR Contact:Bibicoff + MacInnis,
Inc.Terri MacInnis, Dir of IR818-379-8500terri@bibimac.com
United Health Products (PK) (USOTC:UEEC)
Historical Stock Chart
From Aug 2024 to Sep 2024
United Health Products (PK) (USOTC:UEEC)
Historical Stock Chart
From Sep 2023 to Sep 2024